-
ICICI Pru Pharma Healthcare Diag Growth
Equity healthcare
Overview ( as on 07/10/25 )
NAV
₹39.76
Last change
₹-0.26 -0.01%
Fund Size (AUM)
6161.81 Cr
Performance
19.7% (5Y)
Fund Details
ICICI Pru Pharma Healthcare Diag Growth
as of 07/10/25
AUM
6161.81 Cr
Expense Ratio
1.88 %
Benchmark
BSE Healthcare TR INR
ISIN
INF109KC1GE9
Fund Manager
Dharmesh Kakkad
Exit Load
1.0% if redeemed within 0-15 days
0% if redeemed after 15 days
| Fund Performance | 1Y | 3Y | 5Y |
|---|---|---|---|
| ICICI Pru Pharma Healthcare Diag Growth | 4.17% | 26.87% | 19.7% |
| BSE Healthcare TR INR | -2.62% | 22.66% | 16.82% |
Top 10 Holdings
Sun Pharmaceuticals Industries Ltd |
11.71% |
Dr Reddy's Laboratories Ltd |
9.47% |
Divi's Laboratories Ltd |
9.23% |
Cipla Ltd |
7.39% |
Aurobindo Pharma Ltd |
6.53% |
Lupin Ltd |
5.44% |
Alkem Laboratories Ltd |
4.0% |
Mankind Pharma Ltd |
3.5% |
Biocon Ltd |
3.21% |
Gland Pharma Ltd |
2.88% |
Sector Allocation
Healthcare |
97.35% |
Basic Materials |
1.5% |
Financial |
1.15% |
Asset Allocation
-
96%
Equity
-
4%
Others
-
0%
Debt
Risk and Return Category
Risk v/s Category
-
Low
-
Below Average
-
Average
-
Above Average
-
High
Return v/s Category
-
Low
-
Below Average
-
Average
-
Above Average
-
High
Related Funds
-
ICICI Pru Pharma Healthcare Diag Growth
Equity healthcare-
Returns
-
19.7% (5Y)
-
-
ICICI Pru Pharma Healthcare Dg IDCW-R
Equity healthcare-
Returns
-
18.89% (5Y)
-
-
SBI Healthcare Opportunities Growth
Equity healthcare-
Returns
-
18.79% (5Y)
-
-
SBI Healthcare Opportunities IDCW-R
Equity healthcare-
Returns
-
18.79% (5Y)
-
-
UTI Healthcare IDCW-R
Equity healthcare-
Returns
-
16.87% (5Y)
-
-
UTI Healthcare Growth
Equity healthcare-
Returns
-
16.94% (5Y)
-
